Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis (2020)
Source: International journal of pharmaceutics. Unidade: FM
Subjects: LEISHMANIOSE CUTÂNEA, CAMUNDONGOS, ANTIPROTOZOÁRIOS
ABNT
LALATSA, Aikaterini et al. Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis. International journal of pharmaceutics, v. 588, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2020.119734. Acesso em: 18 nov. 2024.APA
Lalatsa, A., Statts, L., Jesus, J. A. de, Adewusi, O., Dea-Ayuela, M. A., Bolas-Fernandez, F., et al. (2020). Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis. International journal of pharmaceutics, 588. doi:10.1016/j.ijpharm.2020.119734NLM
Lalatsa A, Statts L, Jesus JA de, Adewusi O, Dea-Ayuela MA, Bolas-Fernandez F, Laurenti MD, Passero LFD, Serrano DR. Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis [Internet]. International journal of pharmaceutics. 2020 ; 588[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.ijpharm.2020.119734Vancouver
Lalatsa A, Statts L, Jesus JA de, Adewusi O, Dea-Ayuela MA, Bolas-Fernandez F, Laurenti MD, Passero LFD, Serrano DR. Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis [Internet]. International journal of pharmaceutics. 2020 ; 588[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.ijpharm.2020.119734